Abstract Dendritic cells (DC) are professional antigenpresenting cells of the immune system that play a key role in regulating T cell-based immunity. In vivo, the capacity of DC to activate T cells depends on their ability to migrate to the T cell areas of lymph nodes as well as on their maturation state. Depending on their cytokine-secreting proWle, DC are able to skew the immune response in a speciWc direction. In particular, IL-12p70 producing DC drive T cells towards a T helper 1 type response. A serious disadvantage of current clinical grade ex vivo generated monocyte-derived DC is the poor IL-12p70 production. We have investigated the eVects of Toll-like receptor (TLR)-mediated maturation on ex vivo generated human monocyte-derived DC. We demonstrate that in contrast to cytokine-matured DC, DC matured with poly(I:C) (TLR3 ligand) and/or R848 (TLR7/ 8 ligand) are able to produce vast amounts of IL-12p70, but exhibit a reduced migratory capacity. The addition of prostaglandin E 2 (PGE 2 ) improved the migratory capacity of TLR-ligand matured DC while maintaining their IL-12p70 production upon T cell encounter. We propose a novel clinical grade maturation protocol in which TLR ligands poly(I:C) and R848 are combined with PGE 2 to generate DC with both high migratory capacity and IL-12p70 production upon T cell encounter.
Introduction
Dendritic cells (DC) are highly specialized antigen-presenting cells, acting as the sentinels of the immune system [1] .
Immature DC are located in peripheral tissues, where they capture and process antigens. Pro-inXammatory cytokines and microbial products, as well as endogenous factors, can activate immature DC that successively undergo a complex maturation process. This process is characterized by a switch in cytokine and chemokine receptors and up-regulation of MHC complexes and co-stimulatory molecules [2] . Upon maturation, DC migrate via the lymphatic vessels to the secondary lymphoid tissue where they relocate to the T cell zone of the lymph node [3, 4] . Depending on the stimuli received, DC are able to skew naive T cell diVerentiation towards either a T helper 1 (Th1) or Th2 response, thus orchestrating speciWc immune responses.
Because of their central role in the induction of immunity, ex vivo generated monocyte-derived DC have been applied in cancer immunotherapy [5] [6] [7] [8] . Previous clinical studies have demonstrated that eVective induction of speciWc antitumor cytotoxic T cell (CTL) responses require a mature status of the DC [6, 9] . As the activation of T cells occurs in secondary lymphoid organs, the capacity of the ex vivo generated DC to migrate into lymph nodes in vivo appears to be of crucial importance [10] [11] [12] . To date, the most widely applied DC are monocyte-derived DC that are ex vivo matured with a deWned cocktail of the pro-inXammatory cytokines TNF , IL-1 , IL-6 and prostaglandin E 2 (PGE 2 ) [13] . This maturation cocktail leads to phenotypically mature DC with adequate migratory capacities in vitro and in vivo [14] . PGE 2 is included in this maturation cocktail for its participation in podosome dissolution and high-speed migration [15] . Although these DC have shown to be capable of inducing Th1-type tumor-speciWc immune responses in vivo [16] , they secrete only limited amounts of the Th1 inducing cytokine interleukin-12p70 (IL-12p70). On the other hand, the presence of PGE 2 during maturation of DC inhibits the production of IL-12p70 [17, 18] .
IL-12p70 production enhances the ability of DC to induce tumor speciWc IFN producing Th1 cells and CTL and, thereby, the ability to mount an adequate anti-tumor response in vivo [19] . Furthermore, in vitro studies indicated that IL-12p70 positively inXuences the properties of CD8+ T cells to become memory cells and to recruit natural killer (NK) cells [20, 21] . From preclinical studies it is suggested that inadequate IL-12p70 production is one of the hurdles to take in improving the clinical outcomes in cancer immunotherapy studies [22] [23] [24] .
TLR are innate receptors that sense microbial and viral products and trigger DC maturation and cytokine production [25, 26] . Triggering Toll-like receptors (TLR) on DC induces high IL-12p70 production [27] . In mice, the maturation of DC by pro-inXammatory cytokines yields DC that support T cell clonal expansion, but fail to eYciently direct eVector T cell diVerentiation [28] . Interestingly, DC matured in the presence of TLR ligands were able to induce full T cell eVector function and unleashed more potent immune responses [29] . Moreover, cross-presentation of exogenous antigen in MHC class I is enhanced in the presence of TLR ligands [30] .
Monocyte-derived DC express TLR3, TLR4, TLR7, TLR8 and TLR 9 [31, 32] . In 2004, Mailliard et al. [22] developed a clinical grade maturation cocktail to obtain the so-called alpha-type 1 polarized DC, by including IFN and the TLR3 ligand polyinosinic:polycytidylic acid (poly(I:C)) in addition to IL-1 , TNF and IFN . The addition of poly(I:C), a viral dsRNA mimic, to the pro-inXammatory cytokine maturation cocktail dramatically increases the IL12p70 production and subsequently the number of tumor-speciWc CTL in vitro [22, 33] . The TLR7/8 ligand R848 belongs to the imidazoquinolines family and also strongly induces the production of IL-12p70 [34] . Napolitani et al. [27] showed that the combination of TLR3 and TLR7/8 ligands leads to a synergistic IL-12p70 production by DC. However, TLRligand matured DC have an altered expression of regulator of G protein signaling proteins, which may negatively aVect the chemotaxis and migration of these cells [35] .
DC used for clinical vaccination studies require both migratory and cytokine production capacities. Currently, no clinical grade maturation protocol is available that yields DC that combines these desired features. In this study we investigated the application of TLR ligands in ex vivo maturation of DC and propose a clinically applicable maturation protocol consisting of two TLR ligands and PGE 2 , to generate DC that Wt the desired physiological role of migration to the lymph nodes and IL-12p70 production upon T cell contact to induce tumor speciWc IFN producing Th1 cells and CTL.
Materials and methods

Antibodies and immunostaining
The phenotype of the DC populations was determined by Xow cytometry. The following primary monoclonal antibodies (mAbs) or the appropriate isotype controls were used: anti-HLA-ABC (W6/32), anti-HLA DR/DP (Q5/13) and anti-CD80 (all Becton Dickinson, Mountain View, CA, USA); anti-CD83 (Beckman Coulter, Mijdrecht, the Netherlands), anti-CD86 (Pharmingen, San Diego, CA, USA); anti-CCR7 (kind gift of Martin Lipp, Max Planck Institute, Berlin, Germany), anti-CD14 (Beckman Coulter) followed by Goat-anti-Mouse FITC (Roche).
Culture media and cytokines
For DC culture, X-VIVO 15 (BioWhittaker, Walkersville, MD, USA) was supplemented with 2% human serum (HS; serum of six blood donors type AB was pooled) (Sanquin, Bloodbank Zuid-Oost, Nijmegen, the Netherlands), IL-4 (300 U/ml) and GM-CSF (450 U/ml) (both from Strathmann, Hamburg Germany). For maturation the following products were used: recombinant TNF (10 ng/ml; CellGenix, Freiburg, Germany), IL-1 (5 ng/ml or 25 ng/ml; Immunotools, Friesoythe, Germany), PGE 2 (10 g/ml) (Pharmacia & Upjohn, Puurs, Belgium), IL-6 (15 ng/ml) (CellGenix), IFN (10,000 U/ml) (Roche, Mijdrecht, the Netherlands), IFN (1000 U/ml) (Roche), poly(I:C) (20 g/ ml) (Sigma Chemicals Co., St Louis, MO), R848 (3 g/ml) (PharmaTech, Shanghai, China).
Generation of mature DC
BuVy coats were obtained from healthy volunteers according to institutional guidelines. Monocytes were isolated from peripheral blood mononuclear cells (PBMC) by adherence, as described previously [36] . On day 6 or day 7, cells were harvested (immature DC) or maturation cocktail was added for 48 h, after which the cells were harvested.
Migration assay
Flat-bottomed 96-well plates (Costar, Corning Inc. Corning, NY) were coated with 50 l/well Wbronectin (20 g/ ml; Roche) for 60 min at 37°C, washed with PBS and blocked with 100 l/well 0.01% gelatin (Sigma) for 30 min at 37°C. Totally 4,000 DC/well were seeded and recorded for 60 min at 37°C, after which migration tracks of individual DC were analyzed using an automated cell tracking system [37] .
Transwell migration assay
Chemotaxis of DC in response to CCL21 (a ligand for the CCR7 chemokine receptor) was measured in 24-well plates carrying transwell permeable supports with 5 m pore size polycarbonate membrane (Costar). BrieXy, culture medium alone or supplemented with 1-100 ng/ml CCL21 (R&D Systems, Minneapolis, MN) was placed in the lower compartment in a total volume of 600 l, and 10 5 DC were loaded into the inserts in 100 l. Kinesis was determined by measuring the migration in the presence of chemokine in both the lower and upper compartments. Chambers were incubated for 120 min in a 5% CO 2 , humidiWed in a incubator at 37°C. Thirty minutes before the end, 5 mM EDTA was added to the lower compartment. Cells were harvested, centrifugated and resuspended in 100 l PBS. The number of migrated DC (lower chamber) was determined by Xow cytometry by acquiring events for a Wxed time period of 60 s (FACScan, Becton Dickinson). All conditions were tested in duplicate.
IL-12p70 production
The production of IL-12p70 was measured in the supernatants harvested 48h after maturation (1 £ 10 6 immature DC (day 3) in 2 ml per well were matured at day 6 with 250 l of the indicated maturation cocktails), or 24 h after CD40L stimulation (5 £ 10 3 cells/100 l) and mixed lymphocyte reaction (MLR: DC:T cell ratio of 1:5 with 100.000 PBL, Wnal volume 100 l) using a standard sandwich ELISA (Pierce Biotechnology, Rockford). The procedure was performed according to the manufacturer's instructions.
Allogeneic MLR
The allostimulatory capacity of the DC was tested in a mixed lymphocyte reaction (MLR). Allogeneic T cells were co-cultured with diVerently matured DC in a 96-well tissue culture microplate (DC:T cell ratio 1:5 with 100.000 PBL). After 24 h the cytokines in the supernatant were analyzed with a cytometric bead array for human Th1/ Th2 cytokines (BD Biosciences, San Diego, CA) according to the manufacturer's instructions (detecting IL-2, IL-4, IL-5, IL-10, TNF and IFN ).
CD40L stimulation DC were harvested, washed and seeded in a 96-well roundbottomed plate at 50 £ 10 3 cells in 100 l per well. To mimic the interaction with CD40L-expressing Th-cells, CD40 L trimers (Leinco Technologies, Missouri, USA) were added at a concentration of 1 g/ml. Twenty-fourhour supernatants were analyzed by IL-12p70 ELISA.
Antigen-speciWc proliferation assay Cellular responses against the protein keyhole limpet hemocyanin (KLH) were measured in a proliferation assay. In our vaccination studies, KLH is added to the immature DC culture as a immunomonitoring tool. Peripheral blood mononuclear cells (PBMC) were isolated from blood sample from four patients taken after four biweekly vaccinations with mature DC. CD4+ T cells were isolated with a CD4+ T cell isolation kit (Miltenyi Biotech, Bergisch Gladbach, Germany) according to the manufacturer's instructions. The puriWed T cells were plated in a 96-well tissue culture microplate with autologous DC that were cultured with or without KLH and matured with the cytokine cocktail or with poly(I:C) and R848 with or without PGE 2 . After 4 days of culture, 1 Ci/well of tritiated thymidine was added for 8 h, and incorporation of tritiated thymidine was measured in a beta-counter.
Statistics
Data were analyzed using unpaired Student t-test, p-values <0.05 were considered to be statistically signiWcant.
Results and discussion
To Wnd the optimal maturation procedure to generate DC that have both migratory and IL-12p70 producing capacities, we compared the eVect of various maturation cocktails. Cytokine matured DC that are conventionally used in clinical studies were compared with DC matured with poly(I:C) or R848 or both. Pro-inXammatory cytokines such as TNF , IFN and IFN can further enhance the IL12p70 production [22, 27, 38, 39] , however, the eVect on migratory capacity of DC is unknown. In an eVort to improve the migration of TLR-ligand matured DC, while maintaining IL-12p70 production we tested the eVect of these pro-inXammatory cytokines and PGE 2 . Monocytederived DC were, thus, matured as follows: (1) conventional-DC (cDC), matured with the pro-inXammatory cocktail (IL-1 , IL-6, TNF , PGE 2 ) as described by Jonuleit et al. [13] , (2) Toll-like receptor DC (TLR-DC), matured with TLR-ligands alone (poly(I:C), R848, or both; respectively TLR3-DC, TLR7/8-DC or TLR-DC), or (3) poly(I:C) and R848 in combination with pro-inXammatory cytokines (TNF , IFN or IFN ; respectively TNF -TLR-DC, IFN -TLR-DC and IFN -TLR-DC) or prostaglandin E 2 (PGE 2 -TLR-DC).
TLR-ligands and pro-inXammatory cytokines induce DC with a mature phenotype
We Wrst compared the eVect of the diVerent maturation cocktails on the morphology and phenotype of the DC. cDC had the characteristic semi-round appearance with multiple dendrites. In contrast, both TLR3-DC, TLR7/8-DC and TLR-DC showed a more elongated morphology and were more adherent to plastic than cDC (Fig. S1a in  electronic supplementary material) . Although they all expressed the maturation markers CD80, CD86 and MHC class II (Fig. 1a) , the expression of CD83 using the TLR ligands alone for maturation was slightly decreased in comparison with the cDC cocktail and the combination of the TLR-ligands. The increased adherence was reXected in a slightly lower yield and viability of especially TLR7/8-DC and TLR-DC (Fig. S1b in ESM) . Addition of a pro-inXammatory cytokines to the DC matured with TLR-ligands did not change the morphology of the DC. On the contrary, DC cultured with TLR ligands in the presence of PGE 2 were more similar to cDC (Fig. S1a in ESM) .
All diVerent maturation cocktails generate phenotypically mature DC, expressing MHC class I and II, co-stimulatory molecules (CD80, CD86), DC-maturation marker CD83 and chemokine-receptor CCR7, which is consistent with previously published data for the above-mentioned maturation cocktails [6, 22, 27] . These phenotypes were stable and did not change when the maturation cocktail was removed after 48 h and cells were cultured in fresh medium without maturation stimuli over the next 72 h (data not shown). IL-12p70 production is dramatically increased by TLR-ligands and hampered by PGE 2 IL-12p70 secreted by mature DC skews the eVector response towards Th1 type and recruits memory T cells and NK cells. Upon TLR-triggering, DC rapidly produce high levels of IL-12p70 [27] . So, we examined the IL-12p70 production 48 h after addition of the diVerent maturation factors. As reported before [22] , cDC hardly produce any IL-12p70 (Fig. 1b) . DC matured with poly(I:C) or R848 produced elevated levels of IL-12p70, which was further boosted when these ligands were combined (Fig. 1b) , conWrming the synergistic eVect described by Napolitani et al. [27] , which presumably results from concurrent triggering of the intracellular signaling pathways via both MyD88 and TRIF. We found that TLR-DC produce the majority of IL12p70 within 24 h, while little is produced in the next 24 h (data not shown). The addition of IFN or IFN boosted the IL-12p70 production even further (Fig. 1b) . IFN appeared to be the most potent inducer of stable IL-12p70 production, as it resulted in a Wvefold increase in IL-12p70 production.
As expected [17] , the addition of PGE 2 signiWcantly reduced the IL-12p70 production (Fig. 1b) . Thus, also in clinical grade DC preparations, poly(I:C) and R848 strongly induce IL-12p70 secretion during maturation, which is enhanced by type I and II interferons and inhibited by PGE 2 .
Migration of TLR-DC is poor and restored by the addition of PGE 2 cDC exhibit known high migratory capacity in vitro and in vivo [22] , but do not produce IL-12p70. In contrast, DC matured with poly(I:C) and/or R848 produce high levels of IL-12p70 [22, 27, 34] . According to Luft et al. [18] mature DC diVerentiate in either migratory or cytokine secreting cells. For immunotherapy with DC, both qualities are of crucial importance for the induction of potent immune responses. Therefore, we compared the migratory capacity of cDC with TLR-ligand matured DC and tested the eVect of diVerent cytokines and PGE 2 . Random migration of individual DC on Wbronectin was analyzed using an automated cell-tracking system [37] . The migrated distance in 1 h of the TLR-DC was signiWcantly lower compared to the cDC (Fig. 2a) . Detailed analysis of individual cells indicated that the activity of the cells (percentage of time migrating) was signiWcantly lower in all TLR-ligand matured DC (Fig. 2b) . The addition of TNF , IFN or IFN to the TLR-DC had no eVect (Fig. 2) . The addition of PGE 2 to the diVerent maturation cocktails markedly restored the motility of DC in all combinations ( Fig. 2; Fig. S2 in ESM), indicating that PGE 2 stimulates also the motility of TLR-ligand matured DC. PGE 2 is known for its favorable eVect on the migratory capacity of DC. It has a critical role in podosome dissolution and induction of high-speed migration [15] . PGE 2 can accomplish both the expression and activation of CCR7, that allows DC to eYciently migrate towards the lymph node in response to CCL19 [23] and CCL21 [24] . The morphology of our cells upon maturation suggests that the inclusion of PGE 2 in the maturation cocktail results in less adherent cells (Fig. S1a in ESM) what may favor migration. FACS analysis showed that CCR7 expression was more upregulated on cDC and PGE2-TLR-DC compared to TLR-DC (Fig. 3a) . In addition, cDC and PGE 2 -TLR-DC but not TLR-DC migrated similarly towards CCL21 in a chemotaxis assay (Fig. 3b) , demonstrating that CCR7 was expressed in an active form. Thus, unlike the pro-inXammatory cytokines TNF , IFN and IFN , PGE 2 appears to be critical for dendritic cell migration, resulting in comparable motility and chemotactic capabilities of PGE 2 -TLR-DC and cDC. Recently, Lehner et al. [40] showed that DC matured with only Poly(I:C) or R848 are also capable of CCR7-mediated migration, although the number of migrated cells was lower and the cells were strongly adherent. We show here that adding PGE 2 to the combination of Poly(I:C) and R848 generated mature DC that do not only show CCR7-mediated migration but are also less adherent and highly migratory.
PGE 2 does not inhibit secondary IL-12p70 in TLR-ligand matured DC
In clinical vaccination studies, DC should produce IL12p70 after migration to the lymph nodes and upon subsequent T cell contact [40, 41] . At this time point, local and probably low levels of IL-12p70 in the contact area between DC and T cells may suYce to direct naive T cells towards Th1. Moreover, low levels of IL-12p70 will prevent aspeciWc activation of T cells in the microenvironment of the DC. Importantly, IL-12p70 production was not detectable when mature TLR-DC and PGE 2 -TLR-DC were cultured for another 24 h in fresh medium without stimuli (Fig. 4) . To test the ability to produce IL-12p70 upon T cell encounter, we cultured diVerently matured DC in the presence of allogeneic peripheral blood lymphocytes (PBL). cDC demonstrated a very low IL-12p70 producing capacity as shown previously by Mailliard et al. [22] , whereas TLR-DC produced IL-12p70 (Fig. 4) . Interestingly, the production of IL-12p70 by PGE 2 -TLR-DC equaled that of TLR-DC, matured without PGE 2 . This increased production of IL-12p70 after T cell stimulation might be explained by a feedback loop: DC-T cell interaction via CD40-CD40 L triggers the DC to secrete IL-12p70, which activates and attracts T cells but also NK cells to produce IFN [42] , which can in return stimulate the DC to produce more IL-12p70. To test the hypothesis that production of IL-12p70 upon T cell encounter depends on CD40-ligation, diVerently matured DC were stimulated for 24 h with CD40L-trimers. Indeed, stimulation of PGE 2 -TLR-DC with CD40L-trimers increased the production of IL-12p70 (Fig. 4) . Thus, upon either PBL or CD40L stimulation, PGE 2 -TLR-DC and TLR-DC produce similar levels To check whether the secondary production of IL-12p70 upon T cell contact indeed induces a Th1 type eVector response, we analyzed the supernatants from co-cultures of cDC, TLR-DC and PGE 2 -TLR-DC with PBL. It was demonstrated before, that cDC induce expansion of T cells and which subsequently secrete a broad array of cytokines, e.g. IL-2 and IFN [13] . Indeed, cDC induced the secretion of low levels of IFN by the PBL. Importantly, IFN production was approximately nine times higher when PBL were stimulated by TLR-ligand matured DC, both TLR-DC and PGE 2 -TLR-DC (Fig. 5a) . Secretion of Th2-directive IL-4 and IL-5 was comparable. Although TLR-ligand matured DC stimulated the secretion of IL-10, this secretion was decreased when PGE 2 was present during maturation. Thus, indeed TLR-DC and PGE 2 -TLR-DC generated a more pronounced Th1 response. Both cDC, TLR-DC and PGE 2 -TLR-DC are capable of stimulating antigen-speciWc T cells demonstrated by the KLH-speciWc proliferation of CD4 + T cells isolated from patients that had been vaccinated previously with KLH-loaded DC (Fig. 5b) .
Conclusion
Human DC consist of a heterogeneous population of cells that can be classiWed either according to their phenotype or to their function. It has been postulated that at a certain time point in their maturation, DC enter a crossroad where their fate, migratory-type or cytokine producing-type, is determined. The involved factors, as described above (proinXammatory cytokines, PGE 2 , TLR ligands, CD40 L) at least demonstrate the possibility to modulate the properties of ex vivo generated DC. In a physiological situation these factors act on this process in the right time, at the right place, resulting in eVective immune responses. Since vaccinations in cancer immunotherapy are an artiWcial situation, the DC used should potentially perform all the tasks needed. Our data show that the combination TLR3 and TLR7/8 ligands together with PGE 2 , results in clinical grade mature and stable DC with a high migratory capacity and maintained IL-12p70 producing capacity. These DC Wt the desired physiological role of migration to the lymph node and IL-12p70 production upon T cell contact to induce tumor speciWc IFN -producing Th1 cells and CTL. Future studies are needed to demonstrate whether this migratory potential indeed results in more eYcient migration of DC into the lymph nodes and improved immune responses in cancer patients. 
